Literature DB >> 9043954

Role of thymic selection in the development of thymic lymphomas in TCR transgenic mice.

L Strzadala1, A Miazek, J Matuszyk, P Kisielow.   

Abstract

To investigate the role of antigen receptor-mediated interactions in lymphomagenesis we have analyzed the influence of alpha beta TCR-mediated selection on the development of spontaneous thymic lymphomas, which appear with a high (up to 50%) frequency in mice expressing a transgenic TCR specific for the male antigen (HY) in the context of H-2Db molecules. To this end we compared the kinetics and the incidence of thymic lymphomas developing in females and males with selecting (H-2b) and non-selecting (H-2k) MHC molecules. The kinetics of development of thymic lymphomas was similar in positively selecting (H-2b females) and non-selecting (H-2k females and males) environments but significantly slower (P < 0.01) in the negatively selecting environment (H-2b male). Injection of lymphoma cells derived from a H-2b female into the thymus of a H-2b male resulted in strong, antigen-specific inhibition of growth, indicating that the slower kinetics of lymphomagenesis in H-2b males could be due, at least partially, to the sensitivity of oncogenically transformed thymocytes to TCR-mediated negative selection. Phenotypic and functional analysis of lymphoma cells indicated that they originated from the stage of pre-TCR-dependent transition of immature CD4-CD8- to CD4+ CD8+ thymocytes, which in H-2b females and males developed into tumors under different environmental pressures. These results failed to provide convincing evidence for the role of positive selection but provided a strong indication that self antigen-induced negative selection, in addition to its well established role in self tolerance, can occasionally act as a tumor surveillance mechanism by eliminating or suppressing growth of thymocytes undergoing oncogenic transformation.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9043954     DOI: 10.1093/intimm/9.1.127

Source DB:  PubMed          Journal:  Int Immunol        ISSN: 0953-8178            Impact factor:   4.823


  5 in total

1.  Early expression of mature αβ TCR in CD4-CD8- T cell progenitors enables MHC to drive development of T-ALL bearing NOTCH mutations.

Authors:  Kimberly G Laffey; Robert J Stiles; Melissa J Ludescher; Tessa R Davis; Shariq S Khwaja; Richard J Bram; Peter J Wettstein; Venkataraman Ramachandran; Christopher A Parks; Edwin E Reyes; Alejandro Ferrer; Jenna M Canfield; Cory E Johnson; Richard D Hammer; Diana Gil; Adam G Schrum
Journal:  Proc Natl Acad Sci U S A       Date:  2022-06-29       Impact factor: 12.779

2.  A Stat5b transgene is capable of inducing CD8+ lymphoblastic lymphoma in the absence of normal TCR/MHC signaling.

Authors:  Katherine Bessette; Mark L Lang; Roy A Fava; Martin Grundy; Jennifer Heinen; Laurie Horne; Rosanne Spolski; Amin Al-Shami; Herbert C Morse; Warren J Leonard; John A Kelly
Journal:  Blood       Date:  2007-09-21       Impact factor: 22.113

3.  Synergistic control of T cell development and tumor suppression by diacylglycerol kinase alpha and zeta.

Authors:  Rishu Guo; Chi-Keung Wan; Jeffery H Carpenter; Talal Mousallem; Rose-Mary N Boustany; Chien-Tsun Kuan; A Wesley Burks; Xiao-Ping Zhong
Journal:  Proc Natl Acad Sci U S A       Date:  2008-08-08       Impact factor: 11.205

4.  NF-κB in T-cell Acute Lymphoblastic Leukemia: Oncogenic Functions in Leukemic and in Microenvironmental Cells.

Authors:  Nuno R Dos Santos; Marinella N Ghezzo; Ricardo C da Silva; Mónica T Fernandes
Journal:  Cancers (Basel)       Date:  2010-11-05       Impact factor: 6.639

5.  The mitochondrial localization of RelB and NFATx in immature T cells.

Authors:  Izabela Stasik; Andrzej Rapak; Ewa Zioło; Leon Strzadała
Journal:  Cell Mol Biol Lett       Date:  2008-05-06       Impact factor: 5.787

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.